IBDEI0O1 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11839,1,4,0)
 ;;=4^784.42
 ;;^UTILITY(U,$J,358.3,11839,1,5,0)
 ;;=5^Hoarseness
 ;;^UTILITY(U,$J,358.3,11839,2)
 ;;=^338283
 ;;^UTILITY(U,$J,358.3,11840,0)
 ;;=380.10^^82^777^4
 ;;^UTILITY(U,$J,358.3,11840,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11840,1,4,0)
 ;;=4^380.10
 ;;^UTILITY(U,$J,358.3,11840,1,5,0)
 ;;=5^Infective Otitis Externa, Unspecified
 ;;^UTILITY(U,$J,358.3,11840,2)
 ;;=^62807
 ;;^UTILITY(U,$J,358.3,11841,0)
 ;;=272.1^^82^778^1
 ;;^UTILITY(U,$J,358.3,11841,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11841,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,11841,1,5,0)
 ;;=5^Hyperglyceridemia
 ;;^UTILITY(U,$J,358.3,11841,2)
 ;;=^101303
 ;;^UTILITY(U,$J,358.3,11842,0)
 ;;=242.90^^82^778^2
 ;;^UTILITY(U,$J,358.3,11842,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11842,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,11842,1,5,0)
 ;;=5^Hyperthyroidism w/o Crisis
 ;;^UTILITY(U,$J,358.3,11842,2)
 ;;=^267811
 ;;^UTILITY(U,$J,358.3,11843,0)
 ;;=244.9^^82^778^3
 ;;^UTILITY(U,$J,358.3,11843,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11843,1,4,0)
 ;;=4^244.9
 ;;^UTILITY(U,$J,358.3,11843,1,5,0)
 ;;=5^Hypothyroidism
 ;;^UTILITY(U,$J,358.3,11843,2)
 ;;=^123752
 ;;^UTILITY(U,$J,358.3,11844,0)
 ;;=250.01^^82^778^4
 ;;^UTILITY(U,$J,358.3,11844,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11844,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,11844,1,5,0)
 ;;=5^DM, Type I
 ;;^UTILITY(U,$J,358.3,11844,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,11845,0)
 ;;=250.00^^82^778^5
 ;;^UTILITY(U,$J,358.3,11845,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11845,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,11845,1,5,0)
 ;;=5^DM, Type II
 ;;^UTILITY(U,$J,358.3,11845,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,11846,0)
 ;;=250.02^^82^778^6
 ;;^UTILITY(U,$J,358.3,11846,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11846,1,4,0)
 ;;=4^250.02
 ;;^UTILITY(U,$J,358.3,11846,1,5,0)
 ;;=5^DM, Type II Uncontrolled
 ;;^UTILITY(U,$J,358.3,11846,2)
 ;;=^331781
 ;;^UTILITY(U,$J,358.3,11847,0)
 ;;=271.3^^82^778^7
 ;;^UTILITY(U,$J,358.3,11847,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11847,1,4,0)
 ;;=4^271.3
 ;;^UTILITY(U,$J,358.3,11847,1,5,0)
 ;;=5^Glucose Intolerance
 ;;^UTILITY(U,$J,358.3,11847,2)
 ;;=^64790
 ;;^UTILITY(U,$J,358.3,11848,0)
 ;;=790.21^^82^778^8
 ;;^UTILITY(U,$J,358.3,11848,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11848,1,4,0)
 ;;=4^790.21
 ;;^UTILITY(U,$J,358.3,11848,1,5,0)
 ;;=5^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,11848,2)
 ;;=^329895
 ;;^UTILITY(U,$J,358.3,11849,0)
 ;;=789.00^^82^779^1
 ;;^UTILITY(U,$J,358.3,11849,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11849,1,4,0)
 ;;=4^789.00
 ;;^UTILITY(U,$J,358.3,11849,1,5,0)
 ;;=5^Abdomen Pain, Unsp Site
 ;;^UTILITY(U,$J,358.3,11849,2)
 ;;=^303317
 ;;^UTILITY(U,$J,358.3,11850,0)
 ;;=574.20^^82^779^2
 ;;^UTILITY(U,$J,358.3,11850,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11850,1,4,0)
 ;;=4^574.20
 ;;^UTILITY(U,$J,358.3,11850,1,5,0)
 ;;=5^Cholelithiasis
 ;;^UTILITY(U,$J,358.3,11850,2)
 ;;=^18282
 ;;^UTILITY(U,$J,358.3,11851,0)
 ;;=787.91^^82^779^3
 ;;^UTILITY(U,$J,358.3,11851,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11851,1,4,0)
 ;;=4^787.91
 ;;^UTILITY(U,$J,358.3,11851,1,5,0)
 ;;=5^Diarrhea
 ;;^UTILITY(U,$J,358.3,11851,2)
 ;;=^33921
 ;;^UTILITY(U,$J,358.3,11852,0)
 ;;=562.11^^82^779^4
 ;;^UTILITY(U,$J,358.3,11852,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11852,1,4,0)
 ;;=4^562.11
 ;;^UTILITY(U,$J,358.3,11852,1,5,0)
 ;;=5^Diverticulitis
 ;;^UTILITY(U,$J,358.3,11852,2)
 ;;=^270274
 ;;^UTILITY(U,$J,358.3,11853,0)
 ;;=562.10^^82^779^5
 ;;^UTILITY(U,$J,358.3,11853,1,0)
 ;;=^358.31IA^5^2
